Alectinib in pediatric patients with solid or CNS tumors harboring ALK-fusions: Emerging pharmacokinetic data from the iMATRIX alectinib phase I/II open-label, multi-center study Meeting Abstract
| Authors: | Doz, F.; Casanova, M.; Koh, K. N.; Nysom, K.; Canete, A.; Kang, H. J.; Karajannis, M. A.; Hargrave, D. R.; Corradini, N.; Wu, Y.; Wang, H.; Ruf, T.; Manzella, G.; Xu, T.; Tai, Y.; Kassir, N.; Sutaria, D. S.; Mussai, F.; Devlin, C. E.; Gajjar, A. J. |
| Abstract Title: | Alectinib in pediatric patients with solid or CNS tumors harboring ALK-fusions: Emerging pharmacokinetic data from the iMATRIX alectinib phase I/II open-label, multi-center study |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557400701 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.3098 |
| Notes: | Meeting Abstract: 3098 -- Source: Wos |
